“deerfield-management” Archives

in
Entry Author Date Location
Invitae Makes a Precision Oncology Push With $886M Deal for ArcherDx 06/22/20 San Francisco
Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition 06/09/20 New York
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More 04/24/20 National
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Melinta’s Chapter 11 Auction Draws No Bids, Deerfield to Get Assets 03/04/20 New York
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
Oncorus Adds $79.5M to Steer Cancer-Fighting Virus to Human Testing 08/21/19 Boston
WI Watchlist: Microsoft, Exact Sciences, Shine & MKE Tech Hub 07/03/19 Wisconsin
NorthStar Secures $75M+ as Medical Radioisotope Competition Revs Up 04/24/19 Wisconsin
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Clinical Analytics Platform TriNetX Raises $40M to Speed Drug Trials 03/13/19 Boston
Ribon Raises $65M to Pursue PARP-Blocking Pills for Cancer 01/04/19 Boston
InCarda Breathes In $42M for Clinical Tests of Inhalable Heart Drug 11/08/18 San Francisco
Mirum Pharmaceuticals Launches with $120M to Advance Liver Drugs 11/07/18 San Diego
Phoenix Plans to Build New HQ After Inking $15M in New Contracts 08/31/18 Wisconsin
Fresh Off GSK Deal, Gene Therapy Startup Orchard Bags Another $150M 08/13/18 Boston
Alector Snags $133M to Activate Immune Cells Against Neurodegeneration 07/25/18 San Francisco
The Biggest Wisconsin Venture Round of the Decade… Didn’t Happen 06/26/18 Wisconsin
Fresh Off $25M Raise, Generation Adds $100M For Next-Gen Gene Therapy 02/27/18 Boston
MSOE, Noncompetes, NASA, & More: This Week’s Wisconsin Watchlist 10/27/17 Wisconsin
Phoenix Pulls in $12M to Fuel Growth of Neutron Generators 10/26/17 Wisconsin
Bio Roundup: Light For Spark, California Drug Law, IPO Queue & More 10/13/17 National
Homology Med Bags $83.5M More, Fueling Push For Gene Editing Twist 08/01/17 Boston
Scott Gottlieb On Tap to Lead FDA, and Biopharma Exhales 03/10/17 National
Harvard’s Verdine Aims to Retire, Become Full-Time FogPharma CEO 02/23/17 Boston
Rhythm Raises $41M to Bankroll Late-Stage Push For Obesity Drug 02/16/17 Boston
Austin Biotech Xeris Names Edick CEO, Raises $41M in Series C Round 01/10/17 Texas
NY Bio Surge Continues as De Blasio Unveils $500M, 10-Year Life Sci Plan 12/13/16 New York
Celldex, Aiming For More Cancer Drug Combos, Pays $62.5M For Kolltan 11/01/16 New York
Page 1 of 3 next page »